Rhythm Pharmaceuticals Inc
F:1RV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rhythm Pharmaceuticals Inc
F:1RV
|
US |
|
Westports Holdings Bhd
OTC:WSTTF
|
MY |
|
BNP Paribas SA
PAR:BNP
|
FR |
|
M
|
Medtronic PLC
F:2M6
|
IE |
|
Monopar Therapeutics Inc
F:1IY0
|
US |
|
Biodesix Inc
NASDAQ:BDSX
|
US |
|
F
|
Fuji Media Holdings Inc
F:FTN
|
JP |
|
K
|
Kumba Iron Ore Ltd
XBER:KUI
|
ZA |
|
M
|
Mitsubishi Electric Corp
OTC:MIELF
|
JP |
|
W
|
Wacker Neuson SE
XHAM:WAC
|
DE |
|
N
|
Northern Trust Corp
F:NT4
|
US |
|
T
|
Tenaris SA
F:TW11
|
LU |
|
B
|
Brixmor Property Group Inc
F:BXR
|
US |
|
Sogeclair SA
F:2U0
|
FR |
|
Ningbo Tuopu Group Co Ltd
SSE:601689
|
CN |
|
Industrial and Commercial Bank of China Ltd
F:ICKB
|
CN |
|
Bidvest Group Ltd
F:NQL1
|
ZA |
|
RTL Group SA
F:RRTL
|
LU |
|
C
|
Colgate-Palmolive Co
DUS:CPA
|
US |
|
S
|
Singapore Telecommunications Ltd
DUS:SIT4
|
SG |
|
H
|
Humm Group Ltd
F:F5L
|
AU |
|
M3 Inc
OTC:MTHRY
|
JP |
|
A
|
Amgen Inc
BMV:AMGN
|
US |
|
A
|
Altria Group Inc
DUS:PHM7
|
US |
Bankruptcy Probability
Rhythm Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rhythm Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
6.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rhythm Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rhythm Pharmaceuticals Inc has total debt of 98.3m USD. This includes both short-term (0 USD) and long-term (98.3m USD) debt.
You can find a full breakdown on its Balance Sheet.